CATALYST PHARMACEUTICALS, INC.
Recent Filings
All 1,004 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 26, 2026 |
| 8-K/A | 8-K/A | Mar 19, 2026 |
| 8-K | 8-K | Mar 18, 2026 |
| 8-K | 8-K | Feb 25, 2026 |
| 10-K | 10-K | Feb 25, 2026 |
| 4 | FORM 4 FOR 02-17-2026 | Feb 19, 2026 |
| 8-K | 8-K | Jan 12, 2026 |
| 4 | FORM 4 FOR 01-05-2026 | Jan 6, 2026 |
| 4 | FORM 4 FOR 01-05-2026 | Jan 6, 2026 |
| 4 | FORM 4 FOR 12-29-2025 | Dec 30, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Harper Molly | — | Sale | 6,746 @ $23.06 | 2,360 | Dec 12, 2025 |
| Elsbernd Brian | Chief Compliance/Legal Officer | Sale | 40,000 @ $22.70 | 231,039 | Nov 12, 2025 |
| Elsbernd Brian | Chief Compliance/Legal Officer | Sale | 30,000 @ $20.30 | 271,039 | Sep 8, 2025 |
| Elsbernd Brian | Chief Compliance/Legal Officer | Sale | 20,000 @ $20.08 | 188,564 | Sep 3, 2025 |
| Miller Steve | Chief Op. & Scientific Officer | Sale | 115,000 @ $20.28 | 949,663 | Aug 26, 2025 |
| Daly Richard J | President and CEO | Sale | 22,970 @ $20.62 | 226,794 | Aug 26, 2025 |
| Sundaram Preethi | Chief Strategy Officer | Sale | 1,600 @ $26.42 | 41,081 | Jun 10, 2025 |
| MCENANY PATRICK J | — | Sale | 28,252 @ $25.95 | 4,453,450 | Jun 9, 2025 |
| Daly Richard J | President and CEO | Sale | 70,000 @ $24.86 | 199,764 | May 30, 2025 |
| INGENITO GARY | Chief Med. & Reg. Officer | Sale | 44,000 @ $23.63 | 68,873 | May 14, 2025 |